Join the club for FREE to access the whole archive and other member benefits.

Ozlem Tureci

Co-Founder and Chief Medical Officer of BioNTech

Ozlem Tureci is a Co-Founder and Chief Medical Officer of BioNTech. She is also a physician, immunologist, and cancer researcher with translational and clinical experience. Tureci has helped lead the discovery of cancer antigens, the development of mRNA-based individualized and off-the-shelf vaccine candidates and other types of immunotherapies which are currently in clinical development. Tureci leads the clinical development of BioNTech’s “Project Lightspeed,” the company’s successful effort to develop and distribute an mRNA-based vaccine against COVID-19, a historic achievement completed in less than one year. Tureci previously served as CEO and Chief Medical Officer of Ganymed Pharmaceuticals AG, which she co-founded with Ugur Sahin and Christoph Huber. She currently serves as President of the Association for Cancer Immunotherapy (CIMT) in Germany. She is a recent recipient of the German Sustainability Award, among other notable recognitions.

Visit website: https://en.wikipedia.org/wiki/%C3%96zlem_T%C3%BCreci

See also: Company BioNTech - Company developing patient-specific immunotherapies for cancer.

Details last updated 23-Mar-2021

Ozlem Tureci News

Cancer vaccines based on mRNA technology will be available soon

Sky News - 19-Mar-2021

Science behind developing Covid-19 vaccines could bring us cancer shots too

Read more...